Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic study

Journal of Cardiothoracic Surgery

Juan Pablo Umaña¹  Daniel Isaza²  Rodolfo Dennis³  Edgar Hernández-Leiva⁴ 

[1] Department of Cardiovascular Surgery, Instituto de Cardiología-Fundación Cardioinfantil, Bogotá, Colombia;Department of Cardiology, Section of Coronay Care, Instituto de Cardiología-Fundación Cardioinfantil, Bogotá, Colombia;Department of Internal Medicine, Instituto de Cardiología-Fundación Cardioinfantil, Bogotá, Colombia;Department of Cardiology, Section of Cardiovascular Critical Care, Instituto de Cardiología-Fundación Cardioinfantil. Universidad del Rosario, Bogotá, Colombia

关键词: Postoperative care;    Natriuretic peptides;    Inotropic agents;    Hemoglobin;    Cardiac surgery;   

Others  :  824285
DOI  :  10.1186/1749-8090-8-170

 received in 2012-03-08, accepted in 2013-06-25,  发布年份 2013

【 摘 要 】

Introduction

Risk stratification in cardiac surgery significantly impacts outcome. This study seeks to define whether there is an independent association between the preoperative serum level of hemoglobin (Hb), leukocyte count (LEUCO), high sensitivity C-reactive protein (hsCRP), or B-type natriuretic peptide (BNP) and postoperative morbidity and mortality in cardiac surgery.

Methods

Prospective, analytic cohort study, with 554 adult patients undergoing cardiac surgery in a tertiary cardiovascular hospital and followed up for 12 months. The cohort was distributed according to preoperative values of Hb, LEUCO, hsCRP, and BNP in independent quintiles for each of these variables.

Results

After adjustment for all covariates, a significant association was found between elevated preoperative BNP and the occurrence of low postoperative cardiac output (OR 3.46, 95% CI 1.53–7.80, p = 0.003) or postoperative atrial fibrillation (OR 3.8, 95% CI 1.45–10.38). For the combined outcome (death/acute coronary syndrome/rehospitalization within 12 months), we observed an OR of 1.93 (95% CI 1.00–3.74). An interaction was found between BNP level and the presence or absence of diabetes mellitus. The OR for non-diabetics was 1.26 (95% CI 0.61–2.60) and for diabetics was 18.82 (95% CI 16.2–20.5). Preoperative Hb was also significantly and independently associated with the occurrence of postoperative low cardiac output (OR 0.33, 95% CI 0.13–0.81, p = 0.016). Both Hb and BNP were significantly associated with the lengths of intensive care unit and hospital stays and the number of transfused red blood cells (p < 0.002). Inflammatory markers, although associated with adverse outcomes, lost statistical significance when adjusted for covariates.

Conclusions

High preoperative BNP or low Hb shows an association of independent risk with postoperative outcomes, and their measurement could help to stratify surgical risk. The ability to predict the onset of atrial fibrillation or postoperative low cardiac output has important clinical implications. Our results open the possibility of designing studies that incorporate BNP measurement as a routine part of preoperative evaluation, and this strategy could improve upon the standard evaluation in terms of reducing adverse postoperative events.

【 授权许可】

   
2013 Hernández-Leiva et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Warner CD, Weintraub WS, Craver JM, Jones EL, Gott JP, Guyton RA: Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 1997, 96:1575-1579.
• [2]Roques F, Nashef SA, Michel P, et al.: Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 1999, 15(6):816-822. discusión 822-3
• [3]Gogbashian A, Sedrakyan A, Treasure T: EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg 2004, 25:695-700.
• [4]Farrokhyar F, Wang X, Kent R, Lamy A: Early mortality from off-pump and on-pump coronary bypass surgery in Canada: a comparison of the STS and the EuroSCORE risk prediction algorithms. Can J Cardiol 2007, 23:879-883.
• [5]O’Connor GT, Pluma SK, et al.: Multivariate prediction of in-hospital mortality associated UIT coronary artery bypass garft surgery. Circulation 1992, 85:2110-2118.
• [6]Higgins TL, EStafanous FG, et al.: Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA 1992, 267:2344-2348.
• [7]Tuman KJ, Mc Carthy RJ, et al.: Morbidity and duration of ICU stay after cardiac surgery. Chest 1992, 102:36-44.
• [8]Horwich TB, Fonarow GC, et al.: Anemia is associated with worse symptoms, greater inpairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002, 39:1780-1786.
• [9]Lee PC, Kini AS, Ahsan C y c: Anemia is a independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004, 44:541-546.
• [10]Bell ML, Grunwald GK, Baltz JH: Does preoperative hemoglobina independently predict short-term outcomes after coronary artery baypass graft surgery? Ann Thorac Surg 2008, 86:1415-23.
• [11]Pai JK, Pischon T, Ma J y c: Inflamatory markers and the risk of coronary heart disease in Men and women. N Engl J Med 2004, 351:2599-2610.
• [12]Pearson TA, Mensah GA, Alexander W y c: Markers of inflammation and cardiovascular disease. Circulation 2003, 107:499-511.
• [13]Rodeheffer RJ: Measuring plasma B-type natriuretic peptide in heart failure. Good to go in 2004? J Am Coll Cardiol 2004, 44:740-749.
• [14]De Lemos JA, Morrow DA, Bentley JH, et al.: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021.
• [15]Richards AM, Nicholls MG, Espiner EA, et al.: B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792.
• [16]Win HK, Chang SM, Raizner M, et al.: Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 2005, 150:695-700.
• [17]Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, et al.: Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006, 34:995-1000.
• [18]Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al.: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004, 43:1873-1879.
• [19]Kleinbaum DG, Klein M: Modelling strategy for assessing interaction and confounding, in: logistic regression. New York: Springer-Verlag; 2002:191-226.
• [20]Ommen SR, Odell JA, Stanton MS: Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997, 336:1429-1434.
• [21]Asher CR, Miller DP, Grimm RA, Cosgrove DM III, Chung MK: Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol. 1998, 82:892-895.
• [22]Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA: American college of chest physicians. Epidemiology, mechanisms, and risks: American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005, 128:9-16.
• [23]Aranki SF, Shaw DP, Adams DH, Rizzo RJ y c: Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996, 94:390-397.
• [24]Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S: Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation. 2002, 106:75-80.
• [25]Wazni OM, Martin DO, Marrouche NF y c: Plasma B type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004, 110:124-127.
• [26]Maganti MD, Rao V, Borger MA, Ivanov J, David TE: Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 2005, 112(9 Suppl):I448-I452.
• [27]Raymond I, Groenning BA, Hildebrandt PR y c: The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003, 89:745-751.
• [28]Yano Y, Katsuki A, Gabazza EC y c: Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 1999, 84:2353-2356.
• [29]Gæde P, Hildebrandt P, Hess G y c: Plasma N-terminal pro-brain natriuretic peptide as a major risk. Diabetologia 2005, 48:156-163.
• [30]Per-Henrik G, Thomas MC: Brain natriuretic peptide: microalbuminuria for cardiac disease and diabetes? Diabetologia 2005, 48:3-5.
• [31]Cappabianca G, Paparella D, Visicchio G y c: Preoperative C-reactive protein predicts Mid-term outcome after cardiac surgery. Ann Thorac Surg 2006, 82:2170-2178.
• [32]Van der Harst P, Voors AA, Volbeda M: Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. Am J Cardiol 2006, 97:1697-1701.
• [33]Gaudino M, Nasso G, Andreotti F, et al.: Preoperative C reactive protein level and outcome following cardiac surgery. Eur J Cardiothorac Surg 2002, 22:521-526.
• [34]Ahlsson A, Bodin L, Lundblad OH y c: Postoperative atrial fibrillation is Not correlated to C-reactive protein. Ann Thorac Surg 2007, 83:1332-1339.
• [35]Ridker PM, Rifai N, Pfeffer MA y c: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation 1998, 98:839-844.
• [36]Buffon A, Liuzzo G, Biasucci LM y c: Preprocedural serum levels of C- reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999, 34:1512-1521.
• [37]Anand I, McMurray JJ, Whitmore J y c: Anemia and its relationship to clinical outcome in heart failure. Circulation 2004, 110:149-154.
• [38]Kulier A, Levin J, Moser R y c: Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007, 116:471-479.
• [39]Koch CG, Li L, Duncan AI, Mihaljevic T y c: Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006, 81:1650-1657.
• [40]Koch CG, Li L, Duncan AI y c: Morbidity and mortality risk associated with Red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006, 34:1608-1616.
• [41]Hebert PC, Wells G, Blajchman MA y c: Transfusion requirements in critical care investigators, Canadian critical care trials group. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999, 340:409-417.
• [42]Heiss MM: Risk of allogeneic transfusions. Br J Anaesth 1998, 81(suppl 1):16-19.
• [43]Banbury MK, Brizzio ME, Rajeswaran J y c: Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006, 202:131-138.
• [44]Rao S, Jollis J, Harrington R, et al.: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562.